SKI Market

Indian Indices

Nifty

26,027.30 -19.65
(-0.08%)

Sensex

85,213.36 -54.30
( -0.06%)

Bank Nifty

59,461.80 71.85
( 0.12%)

Nifty IT

38,386.30 111.55
( 0.29%)

Global Indices

Nasdaq

48,475.79 -249.23
(-0.51%)

Dow Jones

6,848.05 -73.95
(-1.07%)

Hang Seng

50,163.71 -672.84
(-1.32%)

Nikkei 225

9,761.09 112.06
(1.16%)

Forex

USD-INR

90.19 0.30
(0.34%)

EUR-INR

105.70 1.00
(0.96%)

GBP-INR

120.75 0.96
(0.80%)

JPY-INR

0.58 0.01
(0.91%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5631051

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

19.78

106803.47

EPS(TTM)

Face Value()

Div & Yield %

64.68

0.62

Back

Manglam Global Corporations reports standalone net loss of Rs 0.17 crore in the September 2025 quarter

Nov 14,2025

Net Loss of Manglam Global Corporations reported to Rs 0.17 crore in the quarter ended September 2025 as against net loss of Rs 0.12 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.

26,027.30 -19.65 (-0.08%)

85,213.36 -54.30 ( -0.06%)

59,461.80 71.85 ( 0.12%)

38,386.30 111.55 ( 0.29%)

48,475.79 -249.23 (-0.51%)

6,848.05 -73.95 (-1.07%)

50,163.71 -672.84 (-1.32%)

9,761.09 112.06 (1.16%)

90.19 0.30 (0.34%)

105.70 1.00 (0.96%)

120.75 0.96 (0.80%)

0.58 0.01 (0.91%)